Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae

Infection and Immunity

Volumn 70, Issue 5, 2002, Pages 2526-2534

  Balachandran, Priya ^a   Brooks Walter, Alexis ^a   Virolainen Julkunen, Anni ^a   Hollingshead, Susan K ^a   Briles, David E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CHOLERA TOXIN B SUBUNIT; IMMUNOLOGICAL ADJUVANT; PNEUMOCOCCAL SURFACE PROTEIN C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM CARRIER; CONTROLLED STUDY; DNA TRANSCRIPTION; DRUG EFFICACY; GENE INACTIVATION; IMMUNIZATION; INFECTION PREVENTION; MOUSE; MUTATIONAL ANALYSIS; NASOPHARYNX; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; WILD TYPE;

ADMINISTRATION, INTRANASAL; ANIMALS; BACTEREMIA; BACTERIAL PROTEINS; BLOTTING, SOUTHERN; CARRIER STATE; IMMUNIZATION; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, PNEUMOCOCCAL; RNA, MESSENGER; STREPTOCOCCUS PNEUMONIAE;

EID: 0036118026     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.5.2526-2534.2002     Document Type: Article

References (46)

1. Construction of plasmid vectors for the detection of streptococcal promoters
2. Identification of an active disaccharide unit of a glycoconjugate receptor for pneumococci attaching to human pharyngeal epithelial cells
3. Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Induction of transformation by a deoxyribonucleic acid fraction isolated from pneumococcus type III
4. A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice
5. Differences in virulence of mice among Streptococcus pneumoniae strains of capsular types 2, 3, 4, 5, and 6 are not attributable to differences in pneumolysin production
6. Additive attenuation of virulence of Streptococcus pneumoniae by mutation of genes encoding pneumolysin and other putative pneumococcal virulence proteins
7. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae
8. A strong association between capsular type and mouse virulence among human isolates of Streptococcus pneumoniae
9. PspA and PspC: Their potential for use as pneumococcal vaccines
10. Role of pneumococcal surface protein A in the virulence of Streptococcus pneumoniae
11. The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia
12. Novel purification scheme and functions for a C3-binding protein from Streptococcus pneumoniae
13. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae
14. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor
15. Relationship between colonial morphology and adherence of Streptococcus pneumoniae
16. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid
17. PspC, a pneumococcal surface protein, binds human factor H
18. Role of novel choline binding proteins in virulence of Streptococcus pneumoniae
19. Effect of transforming DNA on growth and frequency of mutation of Streptococcus pneumoniae
20. Characterization of binding of human lactoferrin to pneumococcal surface protein A
21. Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae
22. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component
23. An unmodified heptadecapeptide pheromone induces competence for genetic transformation in Streptococcus pneumoniae
24. Oligosaccharides interfere with the establishment and progression of experimental pneumococcal pneumonia
25. Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function
26. Bacterial vaccines and serotype replacement: Lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae
27. A pneumococcal protein that elicits interleukin-8 from pulmonary epithelial cells
28. Requirement for capsule in colonization by Streptococcus pneumoniae
29. Molecular localization of variable and conserved regions of pspA, and identification of additional pspA homologous sequences in Streptococcus pneumoniae
30. Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA)
31. Differential protein expression in phenotypic variants of Streptococcus pneumoniae
32. The contribution of pneumolysin to the pathogenicity of Streptococcus pneumoniae
33. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae
34. Pyruvate oxidase, as a determinant of virulence in Streptococcus pneumoniae
35. Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice
36. Novel streptococcal-integration shuttle vectors for gene cloning and inactivation
37. Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae
38. Phase variation in colony opacity by Streptococcus pneumoniae
39. Phase variation in pneumococcal opacity: Relationship between colonial morphology and nasopharyngeal colonization
40. Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage and infection with Streptococcus pneumoniae
41. Establishment of a Streptococcus pneumoniae nasopharyngeal model of pneumococcal carriage in adult mice
42. Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection
43. Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis
44. Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA gene
45. Transformation of encapsulated Streptococcus pneumoniae
46. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells